The interplay between infection risk factors of SARS-CoV-2 and mortality: a cross-sectional study from a cohort of long-term care nursing home residents.


Journal

BMC geriatrics
ISSN: 1471-2318
Titre abrégé: BMC Geriatr
Pays: England
ID NLM: 100968548

Informations de publication

Date de publication:
14 02 2022
Historique:
received: 12 08 2021
accepted: 13 01 2022
entrez: 15 2 2022
pubmed: 16 2 2022
medline: 19 2 2022
Statut: epublish

Résumé

Covid-19 pandemic has particularly affected older people living in Long-term Care settings in terms of infection and mortality. We carried out a cross-sectional analysis within a cohort of Long-term care nursing home residents between March first and June thirty, 2020, who were ≥ 65 years old and on whom at least one PCR test was performed. Socio-demographic, comorbidities, and clinical data were recorded. Facility size and community incidence of SARS-CoV-2 were also considered. The outcomes of interest were infection (PCR positive) and death. A total of 8021 residents were included from 168 facilities. Mean age was 86.4 years (SD = 7.4). Women represented 74.1%. SARS-CoV-2 infection was detected in 27.7% of participants, and the overall case fatality rate was 11.3% (24.9% among those with a positive PCR test). Epidemiological factors related to risk of infection were larger facility size (pooled aOR 1.73; P < .001), higher community incidence (pooled aOR 1.67, P = .04), leading to a higher risk than the clinical factor of low level of functional dependence (aOR 1.22, P = .03). Epidemiological risk factors associated with mortality were male gender (aOR 1.75; P < .001), age (pooled aOR 1.16; P < .001), and higher community incidence (pooled aOR 1.19, P = < 0.001) whereas clinical factors were low level of functional dependence (aOR 2.42, P < .001), Complex Chronic Condition (aOR 1.29, P < .001) and dementia (aOR 1.33, P <0.001). There was evidence of clustering for facility and health area when considering the risk of infection and mortality (P < .001). Our results suggest a complex interplay between structural and individual factors regarding Covid-19 infection and its impact on mortality in nursing-home residents.

Sections du résumé

BACKGROUND
Covid-19 pandemic has particularly affected older people living in Long-term Care settings in terms of infection and mortality.
METHODS
We carried out a cross-sectional analysis within a cohort of Long-term care nursing home residents between March first and June thirty, 2020, who were ≥ 65 years old and on whom at least one PCR test was performed. Socio-demographic, comorbidities, and clinical data were recorded. Facility size and community incidence of SARS-CoV-2 were also considered. The outcomes of interest were infection (PCR positive) and death.
RESULTS
A total of 8021 residents were included from 168 facilities. Mean age was 86.4 years (SD = 7.4). Women represented 74.1%. SARS-CoV-2 infection was detected in 27.7% of participants, and the overall case fatality rate was 11.3% (24.9% among those with a positive PCR test). Epidemiological factors related to risk of infection were larger facility size (pooled aOR 1.73; P < .001), higher community incidence (pooled aOR 1.67, P = .04), leading to a higher risk than the clinical factor of low level of functional dependence (aOR 1.22, P = .03). Epidemiological risk factors associated with mortality were male gender (aOR 1.75; P < .001), age (pooled aOR 1.16; P < .001), and higher community incidence (pooled aOR 1.19, P = < 0.001) whereas clinical factors were low level of functional dependence (aOR 2.42, P < .001), Complex Chronic Condition (aOR 1.29, P < .001) and dementia (aOR 1.33, P <0.001). There was evidence of clustering for facility and health area when considering the risk of infection and mortality (P < .001).
CONCLUSIONS
Our results suggest a complex interplay between structural and individual factors regarding Covid-19 infection and its impact on mortality in nursing-home residents.

Identifiants

pubmed: 35164680
doi: 10.1186/s12877-022-02779-0
pii: 10.1186/s12877-022-02779-0
pmc: PMC8842505
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

123

Informations de copyright

© 2022. The Author(s).

Références

J Infect. 2020 Oct;81(4):621-624
pubmed: 32735893
Nat Med. 2020 Dec;26(12):1919-1928
pubmed: 33057181
JAMA Intern Med. 2021 Apr 1;181(4):439-448
pubmed: 33394006
J Aging Soc Policy. 2020 Jul-Oct;32(4-5):297-309
pubmed: 32583751
J Am Geriatr Soc. 2020 Oct;68(10):2153-2162
pubmed: 32735036
Aging (Albany NY). 2020 Jul 13;12(13):12493-12503
pubmed: 32658868
N Engl J Med. 2021 Jul 29;385(5):474-476
pubmed: 34010526
J Am Med Dir Assoc. 2021 Jun;22(6):1142-1145
pubmed: 33865795
J Am Med Dir Assoc. 2021 Sep;22(9):1857-1859
pubmed: 34375654
J Clin Microbiol. 2020 Sep 22;58(10):
pubmed: 32727828
Int J Infect Dis. 2021 Aug;109:192-194
pubmed: 34242767
J Am Geriatr Soc. 2021 Aug;69(8):2063-2069
pubmed: 33861873
JAMA. 2020 Apr 7;323(13):1239-1242
pubmed: 32091533
J Am Med Dir Assoc. 2020 Nov;21(11):1519-1524
pubmed: 33138934
Maturitas. 2020 Nov;141:46-52
pubmed: 33036702
Policy Polit Nurs Pract. 2020 Nov;21(4):191-192
pubmed: 33108980
Cell Discov. 2020 Feb 24;6:11
pubmed: 32133153
J Infect. 2020 Aug;81(2):e16-e25
pubmed: 32335169
N Engl J Med. 2020 Sep 3;383(10):903-905
pubmed: 32459918
Int J Integr Care. 2015 Jun 29;15:e025
pubmed: 26150763
Lancet Respir Med. 2020 Sep;8(9):e70
pubmed: 32771081
Am J Geriatr Psychiatry. 2020 Sep;28(9):989-992
pubmed: 32593495
J Am Med Dir Assoc. 2020 Jul;21(7):900-904
pubmed: 32674816
BMC Geriatr. 2020 Jun 2;20(1):187
pubmed: 32487082
Age Ageing. 2021 Jun 28;50(4):1019-1028
pubmed: 33710281
J Aging Soc Policy. 2020 Jul-Oct;32(4-5):410-415
pubmed: 32441209
Ann Intern Med. 2014 Nov 18;161(10):753-4
pubmed: 25155746
MMWR Morb Mortal Wkly Rep. 2014 Dec 12;63(49):1168-71
pubmed: 25503921
Front Psychiatry. 2020 Sep 29;11:579842
pubmed: 33132939
CMAJ. 2021 May 10;193(19):E672-E680
pubmed: 33972220
J Am Med Dir Assoc. 2020 Jul;21(7):1001-1003
pubmed: 32674812
J Am Geriatr Soc. 2020 Aug;68(8):1653-1656
pubmed: 32484912
J Infect. 2020 Sep;81(3):411-419
pubmed: 32504743
J Pain Symptom Manage. 2020 Oct;60(4):e2-e13
pubmed: 32721500
Front Psychiatry. 2020 Sep 30;11:578465
pubmed: 33132938
Nat Aging. 2021 Jul;1(7):579-584
pubmed: 37117802
Lancet Healthy Longev. 2021 Mar;2(3):e129-e142
pubmed: 33655236
J Am Med Dir Assoc. 2020 Nov;21(11):1555-1559.e2
pubmed: 32978065
Eur Geriatr Med. 2020 Aug;11(4):645-650
pubmed: 32557250
JAMA Netw Open. 2020 Jul 1;3(7):e2016930
pubmed: 32725243
Int Psychogeriatr. 2020 Oct;32(10):1239-1243
pubmed: 32609082
JMIR Public Health Surveill. 2020 Jul 17;6(3):e21163
pubmed: 32629425

Auteurs

Laura Soldevila (L)

International Health Program, Regió Sanitària Metropolitana Nord, Institut Català de la Salut, Badalona, Spain.
Infectious Diseases Unit, Hospital Universitari Germans Trias i Pujol, Badalona, Spain.
Departament de Medicina, Universitat Autònoma de Barcelona, Bellaterra, Spain.
Fight AIDS and Infectious Diseases Foundation, Badalona, Spain.

Núria Prat (N)

Direcció d'Atenció Primària Metropolitana Nord, Institut Català de la Salut, Sabadell, Spain.

Miquel À Mas (MÀ)

Direcció Clínica Territorial de Cronicitat Metropolitana Nord, Institut Català de la Salut, Badalona, Spain.
Department of Geriatrics, Hospital Universitari Germans Trias i Pujol, Badalona, Spain.

Mireia Massot (M)

Direcció d'Atenció Primària Metropolitana Nord, Institut Català de la Salut, Sabadell, Spain.

Ramón Miralles (R)

Direcció Clínica Territorial de Cronicitat Metropolitana Nord, Institut Català de la Salut, Badalona, Spain.
Department of Geriatrics, Hospital Universitari Germans Trias i Pujol, Badalona, Spain.

Josep M Bonet-Simó (JM)

Direcció d'Atenció Primària Metropolitana Nord, Institut Català de la Salut, Sabadell, Spain.

Mar Isnard (M)

Direcció d'Atenció Primària Metropolitana Nord, Institut Català de la Salut, Sabadell, Spain.

Marta Expósito-Izquierdo (M)

Direcció d'Atenció Primària Metropolitana Nord, Institut Català de la Salut, Sabadell, Spain.

Irene Garcia-Sanchez (I)

Direcció d'Atenció Primària Metropolitana Nord, Institut Català de la Salut, Sabadell, Spain.

Sara Rodoreda-Noguerola (S)

Direcció d'Atenció Primària Metropolitana Nord, Institut Català de la Salut, Sabadell, Spain.

Nemesio Moreno (N)

Direcció d'Atenció Primària Metropolitana Nord, Institut Català de la Salut, Sabadell, Spain.

Esther Badia (E)

Direcció d'Atenció Primària Metropolitana Nord, Institut Català de la Salut, Sabadell, Spain.

Genís López (G)

Direcció d'Atenció Primària Metropolitana Nord, Institut Català de la Salut, Sabadell, Spain.

Javier Sevilla (J)

Direcció d'Atenció Primària Metropolitana Nord, Institut Català de la Salut, Sabadell, Spain.

Oriol Estrada (O)

Direcció d'Atenció Primària Metropolitana Nord, Institut Català de la Salut, Sabadell, Spain.

Xavier Vallès (X)

International Health Program, Regió Sanitària Metropolitana Nord, Institut Català de la Salut, Badalona, Spain. xvallesc.mn.ics@gencat.cat.
Fight AIDS and Infectious Diseases Foundation, Badalona, Spain. xvallesc.mn.ics@gencat.cat.
Institut per la Recerca en Ciències de la Salut Germans Trias i Pujol, Badalona, Spain. xvallesc.mn.ics@gencat.cat.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH